← SynDRA
DOXOFYLLINE
SynDRA canonical compound SYN0025491 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PDE4D |
|---|
| Mechanism of action | Adenosine receptor antagonist |
|---|
| Indication | asthma |
|---|
| Disease area | pulmonary |
|---|
All known targets
- ADORA1
- PDE4A
- PDE4B
- PDE4C
- PDE4D
Mechanisms of action (all sources)
- Adenosine receptor antagonist
Drug classes
- Anti-Asthmatic Agents
- Antitussive Agents
- Bronchodilator Agents
- Central Nervous System Agents
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Phosphodiesterase Inhibitors
- Respiratory System Agents
ATC classes
- R03D · OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Cross-references
Synonyms
- ansimar
- dioxyfilline
- doxophylline
- Doxofilina
- Ansimar
- Dioxyfilline
- Doxophylline
- Synasma
- Ventax
- ABC-12/3
- NSC-759645
- Ansimar (TN)
- Doxofyllinum
- 7-(1,3-Dioxolan-2-ylmethyl)theophylline
- MPM23GMO7Z
- NSC 759645
- CHEBI:94714
- DTXCID002968
- TMDO
- doxofillina
- 2-(7'-theophyllinemethyl)1,3-dioxolane
- RefChem:590414
- R03DA11
- Maxivent
- 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione
- MFCD00865218
- NCGC00159330-02
- 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-purine-2,6-dione
- 7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethyl-1H-purine-2,6-dione
- Doxofylline [USAN:INN]
- Doxofilina [INN-Spanish]
- Doxofyllinum [INN-Latin]
- CAS-69975-86-6
- SR-01000789760
- EINECS 274-239-6
- UNII-MPM23GMO7Z
- BRN 0561195
- 2-(7'-Theophyllinemethyl)-1,3-dioxolane
Look up DOXOFYLLINE in the interactive SynDRA portal →